DNAX Stock Overview
DNA Brands, Inc. provides energy drinks. It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
DNA Brands, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0005 |
| 52 Week High | US$0.0039 |
| 52 Week Low | US$0.0004 |
| Beta | 0 |
| 1 Month Change | -16.67% |
| 3 Month Change | -37.50% |
| 1 Year Change | -82.76% |
| 3 Year Change | -99.93% |
| 5 Year Change | -99.99% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| DNAX | US Beverage | US Market | |
|---|---|---|---|
| 7D | 0% | 3.2% | 1.0% |
| 1Y | -82.8% | -2.1% | 21.9% |
Return vs Industry: DNAX underperformed the US Beverage industry which returned -1.9% over the past year.
Return vs Market: DNAX underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| DNAX volatility | |
|---|---|
| DNAX Average Weekly Movement | 21.8% |
| Beverage Industry Average Movement | 5.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: DNAX's share price has been volatile over the past 3 months.
Volatility Over Time: DNAX's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Adrian Patasar | www.dnabrandsinc.com |
DNA Brands, Inc. provides energy drinks. It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. The company markets its products for retailers, restaurants, bars, and clubs.
DNA Brands, Inc. Fundamentals Summary
| DNAX fundamental statistics | |
|---|---|
| Market cap | US$371.38k |
| Earnings (TTM) | -US$1.25m |
| Revenue (TTM) | US$249.01k |
0.0x
P/S Ratio0.0x
P/E RatioIs DNAX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DNAX income statement (TTM) | |
|---|---|
| Revenue | US$249.01k |
| Cost of Revenue | US$0 |
| Gross Profit | US$249.01k |
| Other Expenses | US$1.49m |
| Earnings | -US$1.25m |
Last Reported Earnings
Dec 31, 2020
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did DNAX perform over the long term?
See historical performance and comparison